# US 2024/0199689 A1 · Method for the analysis of related substances in germinal peptide preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0199689 A1
- Document ID: US20240199689A1
- Status: Published application
- Kind: A1
- Application number: 18/591,010
- Filed: 2024-02-29
- Published: 2024-06-20
- Earliest claimed: 2022-08-02
- Assignees: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited
- Applicants: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited
- Inventors: Zhijun XIE; Ping TAN
- Web page: https://patentgrep.com/patent/US20240199689A1

## CPC

- C07K 1/16: by chromatography
- C07K 1/20: Partition-, reverse-phase or hydrophobic interaction chromatography
- G01N 30/34: of fluid composition, e.g. gradient (G01N30/36 takes precedence)
- G01N 30/88: Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N 30/74: Optical detectors {(measurement of intensity, velocity, spectral content, polarisation, or phase of infrared, visible or ultraviolet light G01J)}
- G01N 2030/8831: {involving peptides or proteins}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for analysis of related substances in a germinal peptide preparation is provided. The method refers to high-performance liquid chromatography (HPLC), and the HPLC is conducted under the following chromatographic conditions: a chromatographic column: a YMC-Triart C18 chromatographic column, 4.6×150 mm, 3 μm; a column temperature: 35° C.; an injection volume: 100 μL; a detection wavelength: 210 nm; a mobile phase A: a 0.1% trifluoroacetic acid (TFA) aqueous solution; a mobile phase B: 0.1% TFA-acetonitrile; and gradient elution as follows: 0 min: a volume ratio of the mobile phase A to the mobile phase B is 100:0; 8 min to 13 min: the volume ratio of the mobile phase A to the mobile phase B is 85:15; and 13 min to 20 min: the volume ratio of the mobile phase A to the mobile phase B is 100:0.

## Claims

### Claim 1

A method for an analysis of related substances in a germinal peptide preparation, comprising the following steps:
(1) preparing a sample; and
(2) testing the sample by high-performance liquid chromatography, wherein a chromatographic column with octadecylsilane-bonded silica gel as a packing is adopted for the high-performance liquid chromatography; and mobile phases for the high-performance liquid chromatography comprise a mobile phase A and a mobile phase B, wherein the mobile phase A is a trifluoroacetic acid aqueous solution with a volume ratio of the trifluoroacetic acid to water being 0.05:100 to 0.15:100, and the mobile phase B is trifluoroacetic acid-acetonitrile.

### Claim 2 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein a volume ratio of trifluoroacetic acid to acetonitrile in the mobile phase B is 0.05:100 to 0.15:100.

### Claim 3 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein a column temperature of the chromatographic column is 30° C. to 40° C.

### Claim 4 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein an injection volume for the high-performance liquid chromatography is 90 μL to 110 μL.

### Claim 5 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein a detection wavelength for the high-performance liquid chromatography is 210 nm.

### Claim 6 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein the chromatographic column is selected from one of a Waters chromatographic column, an Agilent chromatographic column, a Thermo chromatographic column, a Phenomenex chromatographic column, a Shimatsu chromatographic column, or a YMC chromatographic column.

### Claim 7 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein the chromatographic column has a specification of 4.6×150 mm, 3 μm.

### Claim 8 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein the high-performance liquid chromatography adopts a gradient elution as follows:
0 min: a volume ratio of the mobile phase A to the mobile phase B is 100:0;
8 min: the volume ratio of the mobile phase A to the mobile phase B is 83:17 to 87:13;
8 min to 13 min: the volume ratio of the mobile phase A to the mobile phase B is 83:17 to 87:13; and
13 min to 20 min: the volume ratio of the mobile phase A to the mobile phase Bis 100:0.

### Claim 9 (depends on 1)

The method for the analysis of the related substances in the germinal peptide preparation according to claim 1, wherein the high-performance liquid chromatography adopts a gradient elution as follows:
0 min: a volume ratio of the mobile phase A to the mobile phase B is 100:0;
8 min: the volume ratio of the mobile phase A to the mobile phase B is 85:15;
8 min to 13 min: the volume ratio of the mobile phase A to the mobile phase B is 85:15; and
13 min to 20 min: the volume ratio of the mobile phase A to the mobile phase B is 100:0.

### Claim 10 (depends on 1)

A method for controlling a quality of a germinal peptide preparation, comprising using the method for the analysis of the related substances in the germinal peptide preparation according to claim 1.

### Claim 11 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, a volume ratio of trifluoroacetic acid to acetonitrile in the mobile phase B is 0.05:100 to 0.15:100.

### Claim 12 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, a column temperature of the chromatographic column is 30° C. to 40° C.

### Claim 13 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, an injection volume for the high-performance liquid chromatography is 90 μL to 110 μL.

### Claim 14 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, a detection wavelength for the high-performance liquid chromatography is 210 nm.

### Claim 15 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, the chromatographic column is selected from one of a Waters chromatographic column, an Agilent chromatographic column, a Thermo chromatographic column, a Phenomenex chromatographic column, a Shimatsu chromatographic column, or a YMC chromatographic column.

### Claim 16 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, the chromatographic column has a specification of 4.6×150 mm, 3 μm.

### Claim 17 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, the high-performance liquid chromatography adopts a gradient elution as follows:
0 min: a volume ratio of the mobile phase A to the mobile phase B is 100:0;
8 min: the volume ratio of the mobile phase A to the mobile phase B is 83:17 to 87:13;
8 min to 13 min: the volume ratio of the mobile phase A to the mobile phase B is 83:17 to 87:13; and
13 min to 20 min: the volume ratio of the mobile phase A to the mobile phase B is 100:0.

### Claim 18 (depends on 10)

The method for controlling the quality of the germinal peptide preparation according to claim 10, wherein in the method for the analysis of the related substances in the germinal peptide preparation, the high-performance liquid chromatography adopts a gradient elution as follows:
0 min: a volume ratio of the mobile phase A to the mobile phase B is 100:0;
8 min: the volume ratio of the mobile phase A to the mobile phase B is 85:15;
8 min to 13 min: the volume ratio of the mobile phase A to the mobile phase B is 85:15; and
13 min to 20 min: the volume ratio of the mobile phase A to the mobile phase B is 100:0.
